Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nabeel El-Bardeesy, Ph.D.

Concepts (323)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Nabeel El-Bardeesy's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Nabeel El-Bardeesy has written about over time.
Tumor Suppressor Protein p14ARF, 8 publications between 2000 and 2006, average publication date November 2002. Genes, ras, 11 publications between 1999 and 2018, average publication date May 2006. AMP-Activated Protein Kinases, 9 publications between 2002 and 2019, average publication date February 2008. Cell Transformation, Neoplastic, 6 publications between 2001 and 2018, average publication date August 2010. Pancreatic Neoplasms, 20 publications between 2001 and 2025, average publication date April 2012. Carcinoma, Pancreatic Ductal, 10 publications between 2003 and 2025, average publication date November 2013. Reactive Oxygen Species, 3 publications between 2006 and 2023, average publication date August 2015. NF-E2-Related Factor 2, 2 publications between 2016 and 2023, average publication date November 2019. Cysteine, 2 publications between 2016 and 2024, average publication date June 2020. Isocitrate Dehydrogenase, 5 publications between 2016 and 2024, average publication date June 2020. Cyclic AMP-Dependent Protein Kinases, 2 publications between 2018 and 2023, average publication date October 2020. Drug Resistance, Neoplasm, 6 publications between 2016 and 2024, average publication date December 2020. Molecular Targeted Therapy, 4 publications between 2015 and 2024, average publication date April 2021. Bile Duct Neoplasms, 11 publications between 2016 and 2024, average publication date May 2021. Cholangiocarcinoma, 15 publications between 2016 and 2024, average publication date June 2021. Receptor, Fibroblast Growth Factor, Type 1, 1 publications between 2021 and 2021, average publication date June 2021. Receptor, Fibroblast Growth Factor, Type 2, 8 publications between 2016 and 2024, average publication date October 2021. Bile Ducts, Intrahepatic, 5 publications between 2022 and 2024, average publication date October 2022.

To see the data from this visualization as text, click here.
El-Bardeesy's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (323)
Explore
_
Co-Authors (117)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.